글로벌 시스틴뇨증 치료 시장 - 2028년까지의 산업 동향 및 예측

시스틴뇨증 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 시스틴뇨증 치료가 2021-2028년 예측 기간 동안 약 6.00%의 CAGR을 보일 것이라고 분석했습니다. 표적 치료 모드에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동의 급증, 의료 인프라 개발에 대한 지출 증가는 시스틴뇨증 치료 시장 성장에 기인하는 주요 요인입니다.

시스틴뇨증은 소변에 시스틴 수치가 축적되는 희귀 유전성 질환입니다. 이는 반복적인 시스틴 신장 결석의 발병으로 이어집니다. 시스틴-리신-아르기닌-오르니티누리아라고도 알려진 시스틴뇨증은 SLC3A1 및 SLC7A9 유전자의 결함으로 인해 발생합니다.

규제 당국으로부터 특별 지정이 증가하고 치료 옵션에 대한 인식이 높아지는 것은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 유전 질환의 유병률 증가, 처방약을 얻기 위한 온라인 약국의 인기 상승, 시장 참여자 간의 전략적 협력 비율의 급증은 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가는 수익성 있는 시장 성장 기회를 창출할 또 다른 간접적인 결정 요인입니다.

그러나 이 질병의 희귀성으로 인한 인식 부족과 개발도상국과 저개발 경제권에서의 불리한 보상 시나리오는 시장 성장에 큰 도전이 될 것입니다. 또한, 이 질병에 대한 연구 개발 능력과 제한된 치료 옵션과 관련된 높은 비용은 시장 성장률을 더욱 떨어뜨릴 것입니다. 시장에서 약물 승인에 부과된 엄격한 규제도 시장 성장률을 방해할 것입니다.

This cystinuria treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cystinuria treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cystinuria Treatment Market Scope and Market Size

The cystinuria treatment market is segmented on the basis of type, therapy type, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the cystinuria treatment market is segmented into cystinuria, type I, cystinuria, type II, cystinuria and type III.
• On the basis of therapy type, the cystinuria treatment market is segmented into gene therapy, copper injection therapy.
• On the basis of drugs, the cystinuria treatment market is segmented into penicillamine, tiopronin, captopril and others.  
• On the basis of route of administration, the cystinuria treatment market is segmented into oral and injectable.
• On the basis of end users, the cystinuria treatment market is segmented into hospitals, home care, speciality clinics, and others.
• On the basis of distribution channel, the cystinuria treatment market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Cystinuria Treatment Market Country Level Analysis

The cystinuria treatment market is analysed and market size insights and trends are provided by country, type, therapy type, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the cystinuria treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the cystinuria treatment market owing to the surge in use and awareness about cystinuria treatments and procedures. Asia-Pacific is projected to undergo substantial gains during the forecast period and score the highest CAGR. This is because of the rising expenditure to develop healthcare infrastructure, growing cases of cystinuria and increasing personal disposable income.

The country section of the cystinuria treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The cystinuria treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Cystinuria Treatment Market Share Analysis

The cystinuria treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cystinuria treatment market.

시스틴뇨증 치료 시장 보고서에 포함된 주요 기업으로는 Incepta Pharmaceuticals Ltd., Aktis Pharma India Pvt Ltd., Mankind Pharma, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, ANI Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC, Abbott, Aurobindo Pharma, Mylan NV, Bausch Health Companies Inc., Zhejiang Huahai Pharmaceutical Co., Ltd, WOCKHARDT, Amerigen Pharmaceuticals Limited, Travere Therapeutics, Inc., F. Hoffmann-La Roche Ltd, Astrazeneca, Pfizer Inc., Mission Pharmacal Company 등이 있습니다. 국내 및 글로벌 기업 중에서도 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-50283